Novartis says EU has approved best-selling hypertension drug …



Novartis: EU approves Diovan for childrenGENEVA — Pharmaceutical maker Novartis AG said Friday the European Union has approved its best-selling hypertension drug Diovan for treatment of children aged 6-18.

View full post on hypertension – Google Blog Search

Loading...

Comments are closed.

Get Adobe Flash playerPlugin by wpburn.com wordpress themes